BCL2 mutation	Chronic Lymphocytic Leukemia	BCL2 mutation	Chronic Lymphocytic Leukemia	NX-2127 Sensitive: C3 – Early Trials NX-2127 Sensitive : C3	NX-2127 Sensitive: C3 – Early Trials NX-2127 Sensitive : C3
BTK mutation	Chronic Lymphocytic Leukemia	BTK mutation	Chronic Lymphocytic Leukemia	NX-2127 Sensitive: C3 – Early Trials NX-2127 Sensitive : C3	NX-2127 Sensitive: C3 – Early Trials NX-2127 Sensitive : C3
BTK C481S	Diffuse Large B Cell Lymphoma	BTK C481S	Diffuse Large B Cell Lymphoma	ABBV-101 Sensitive: D – Preclinical ABBV-101 Sensitive : D	ABBV-101 Sensitive: D – Preclinical ABBV-101 Sensitive : D

BTK degrader

Associations(3)